Filing Details
- Accession Number:
- 0001209191-17-043174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-05 15:47:37
- Reporting Period:
- 2017-06-30
- Filing Date:
- 2017-07-05
- Accepted Time:
- 2017-07-05 15:47:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1571498 | Epizyme Inc. | EPZM | Pharmaceutical Preparations (2834) | 261349956 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1632720 | E. Andrew Singer | C/O Epizyme, Inc. 400 Technology Square Cambridge MA 02139 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Commons Stock, Par Value $0.0001 | Disposition | 2017-06-30 | 3,024 | $15.50 | 40,529 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person to cover taxes associated with the vesting of his restricted stock.
Billionaire Hedge Funds
